#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Optic glioma Arteriosclerosis Anti-neutrophil cytoplasmic antibody positive vasculitis Osteomyelitis Noonan syndrome Ventricular fibrillation Crigler-Najjar syndrome Demyelination Astrocytoma malignant Advanced systemic mastocytosis Metastatic malignant melanoma Oropharyngeal squamous cell carcinoma Encephalopathy neonatal Squamous cell carcinoma of head and neck Haemophilia A with anti factor VIII More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Life with Disease Pemphigus – Diagnostics Haemophagocytic lymphohistiocytosis – Basic Information Mucopolysaccharidosis Andersen-Tawil syndrome KBG syndrome KBG syndrome – Trials in Disease Primary immunodeficiency syndrome Langerhans’ cell histiocytosis – Diagnostics Skin angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Utreloxastat ZIMISLECEL Gsk3858279 D5-Ethyl-Beta-D-Glucuronide AZD6234 Odronextamab Levodopa Amg 193 Nadroparin Calcium Ondansetron Hydrochloride Gentamicin Timrepigene Emparvovec Xevinapant Pbf-999 Sodium Chloride Zalunfiban Candesartan Cilexetil Omp64 Eight Treg Cldn6 Rna-Lpx More therapies…

    Learn about Your Condition

    Urticaria cholinergic Immunosuppression Ovarian cancer Primary adrenal insufficiency Dent's disease Cystic fibrosis lung Subarachnoid haemorrhage Obsessive-compulsive disorder Laparoscopic surgery Non-small cell lung cancer Transplant rejection Strongyloidiasis Ejection fraction normal Glycogen storage disorder Myofascial pain syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemodialysis
    • Peritoneal dialysis
    • Atrial fibrillation
    Investigated Drugs:
    • Warfarin Sodium
    Denmark

  • Study on Remifentanil and Sodium Chloride for Safe Intubation in Stable Newborns

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endotracheal intubation
    Investigated Drugs:
    • Remifentanil
    • Sodium Chloride
    Belgium

  • Study on Walking Rehabilitation for Hip or Knee Osteoarthritis Using Ketoprofen and Drug Combination for Patients with Osteoarthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Diclofenac Epolamine
    • Niflumic Acid
    • Ibuprofen
    France

  • Study on Imlifidase and Drug Combination for Kidney Transplant in Highly Sensitized Children

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    Investigated Drugs:
    • Anti-Human T-Lymphocyte Immunoglobulin From Rabbits
    • Immunglobulin
    • Imlifidase
    Finland France Spain Sweden

  • Study on Blood Pressure Management with Amiloride Hydrochloride, Indapamide, and Furosemide for Patients with Uncontrolled Hypertension and Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypertension
    • Chronic kidney disease
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    • Hydrochlorothiazide
    France

  • Study on Zoledronic Acid Following Denosumab for Osteoporosis Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Zoledronic Acid
    Denmark
Previous Page
1 … 576 577 578 579 580 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!